Skip to main content
Erschienen in: memo - Magazine of European Medical Oncology 4/2019

21.11.2019 | short review

Surgery in renal cell carcinoma—when, whom and how?

verfasst von: Sebastian Lenart, MD, Ingrid Berger, Nikolaus Hartig, Stephan Madersbacher, Anton Ponholzer

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Summary

Surgical resection of RCC should be the aim for cure of localized or locally advanced RCC, either by partial or radical nephrectomy, depending on tumor size and patient’s performance status. In cT1 stages partial nephrectomy is recommended. In metastatic stage, immediate CN can be performed in patients with good performance status, who do not need systemic therapy because of oligometatastic disease with feasibility of complete resection.
Literatur
1.
Zurück zum Zitat MacLennan S, et al. Systematic review of oncological outcomes following surgical management of localised renal cancer. Eur Urol. 2012;61(5):972–93.PubMed MacLennan S, et al. Systematic review of oncological outcomes following surgical management of localised renal cancer. Eur Urol. 2012;61(5):972–93.PubMed
2.
Zurück zum Zitat Gill IS, et al. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol. 2007;178(1):41–6.PubMed Gill IS, et al. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol. 2007;178(1):41–6.PubMed
3.
Zurück zum Zitat Marszalek M, et al. Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients. Eur Urol. 2009;55(5):1171–8.PubMed Marszalek M, et al. Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients. Eur Urol. 2009;55(5):1171–8.PubMed
4.
Zurück zum Zitat Hemal AK, et al. Laparoscopic versus open radical nephrectomy for large renal tumors: a long-term prospective comparison. J Urol. 2007;177(3):862–6.PubMed Hemal AK, et al. Laparoscopic versus open radical nephrectomy for large renal tumors: a long-term prospective comparison. J Urol. 2007;177(3):862–6.PubMed
5.
Zurück zum Zitat Tait C, et al. Long-term oncologic outcomes of laparoscopic radical nephrectomy for kidney cancer resection: Dundee cohort and metaanalysis of observational studies. Surg Endosc. 2011;25(10):3154–61.PubMed Tait C, et al. Long-term oncologic outcomes of laparoscopic radical nephrectomy for kidney cancer resection: Dundee cohort and metaanalysis of observational studies. Surg Endosc. 2011;25(10):3154–61.PubMed
7.
Zurück zum Zitat Bianchi M, et al. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma. Urol Oncol. 2014;32(1):46e1–46e7. Bianchi M, et al. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma. Urol Oncol. 2014;32(1):46e1–46e7.
8.
Zurück zum Zitat Van Poppel H, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2011;59(4):543–52.PubMed Van Poppel H, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2011;59(4):543–52.PubMed
9.
Zurück zum Zitat Abdollah F, et al. Testing the external validity of the EORTC randomized trial 30904 comparing overall survival after radical nephrectomy vs nephron-sparing surgery in contemporary North American patients with renal cell cancer. BJU Int. 2018;121(3):345–7.PubMed Abdollah F, et al. Testing the external validity of the EORTC randomized trial 30904 comparing overall survival after radical nephrectomy vs nephron-sparing surgery in contemporary North American patients with renal cell cancer. BJU Int. 2018;121(3):345–7.PubMed
10.
Zurück zum Zitat Scosyrev E, et al. Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. Eur Urol. 2014;65(2):372–7.PubMed Scosyrev E, et al. Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. Eur Urol. 2014;65(2):372–7.PubMed
11.
Zurück zum Zitat MacLennan S, et al. Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer. Eur Urol. 2012;62(6):1097–117.PubMed MacLennan S, et al. Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer. Eur Urol. 2012;62(6):1097–117.PubMed
12.
Zurück zum Zitat Woldu SL, et al. Who really benefits from nephron-sparing surgery? Urology. 2014;84(4):860–7.PubMed Woldu SL, et al. Who really benefits from nephron-sparing surgery? Urology. 2014;84(4):860–7.PubMed
13.
Zurück zum Zitat Larcher A, et al. Elective nephron sparing surgery decreases other cause mortality relative to radical nephrectomy only in specific subgroups of patients with renal cell carcinoma. J Urol. 2016;196(4):1008–13.PubMed Larcher A, et al. Elective nephron sparing surgery decreases other cause mortality relative to radical nephrectomy only in specific subgroups of patients with renal cell carcinoma. J Urol. 2016;196(4):1008–13.PubMed
14.
Zurück zum Zitat Weight CJ, et al. Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol. 2010;183(4):1317–23.PubMed Weight CJ, et al. Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol. 2010;183(4):1317–23.PubMed
15.
Zurück zum Zitat Lane BR, et al. Survival and functional stability in chronic kidney disease due to surgical removal of nephrons: importance of the new baseline glomerular filtration rate. Eur Urol. 2015;68(6):996–1003.PubMed Lane BR, et al. Survival and functional stability in chronic kidney disease due to surgical removal of nephrons: importance of the new baseline glomerular filtration rate. Eur Urol. 2015;68(6):996–1003.PubMed
16.
Zurück zum Zitat Bagrodia A, et al. Comparison of rates and risk factors for development of osteoporosis and fractures after radical or partial nephrectomy. Urology. 2011;78(3):614–9.PubMed Bagrodia A, et al. Comparison of rates and risk factors for development of osteoporosis and fractures after radical or partial nephrectomy. Urology. 2011;78(3):614–9.PubMed
17.
Zurück zum Zitat Woldrich J, et al. Comparison of rates and risk factors for development of anaemia and erythropoiesis-stimulating agent utilization after radical or partial nephrectomy. BJU Int. 2012;109(7):1019–25.PubMed Woldrich J, et al. Comparison of rates and risk factors for development of anaemia and erythropoiesis-stimulating agent utilization after radical or partial nephrectomy. BJU Int. 2012;109(7):1019–25.PubMed
18.
Zurück zum Zitat Capitanio U, et al. Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function. Eur Urol. 2015;67(4):683–9.PubMed Capitanio U, et al. Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function. Eur Urol. 2015;67(4):683–9.PubMed
19.
Zurück zum Zitat Gong EM, et al. Comparison of laparoscopic and open partial nephrectomy in clinical T1a renal tumors. J Endourol. 2008;22(5):953–7.PubMed Gong EM, et al. Comparison of laparoscopic and open partial nephrectomy in clinical T1a renal tumors. J Endourol. 2008;22(5):953–7.PubMed
20.
Zurück zum Zitat Peng, B., et al., Retroperitoneal laparoscopic nephrectomy and open nephrectomy for radical treatment of renal cell carcinoma: A comparison of clinical outcomes. Acad J Second Mil Med Univ. 2006;27:1167–1169 Peng, B., et al., Retroperitoneal laparoscopic nephrectomy and open nephrectomy for radical treatment of renal cell carcinoma: A comparison of clinical outcomes. Acad J Second Mil Med Univ. 2006;27:1167–1169
21.
Zurück zum Zitat Gratzke C, et al. Quality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron-sparing surgery in patients with renal cell carcinoma. BJU Int. 2009;104(4):470–5.PubMed Gratzke C, et al. Quality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron-sparing surgery in patients with renal cell carcinoma. BJU Int. 2009;104(4):470–5.PubMed
22.
Zurück zum Zitat Asimakopoulos AD, et al. Robotic radical nephrectomy for renal cell carcinoma: a systematic review. BMC Urol. 2014;14:75.PubMedPubMedCentral Asimakopoulos AD, et al. Robotic radical nephrectomy for renal cell carcinoma: a systematic review. BMC Urol. 2014;14:75.PubMedPubMedCentral
23.
Zurück zum Zitat Jeong IG, et al. Association of robotic-assisted vs laparoscopic radical nephrectomy with Perioperative outcomes and health care costs, 2003 to 2015. JAMA. 2017;318(16):1561–8.PubMedPubMedCentral Jeong IG, et al. Association of robotic-assisted vs laparoscopic radical nephrectomy with Perioperative outcomes and health care costs, 2003 to 2015. JAMA. 2017;318(16):1561–8.PubMedPubMedCentral
24.
Zurück zum Zitat Masson-Lecomte A, et al. A prospective comparison of the pathologic and surgical outcomes obtained after elective treatment of renal cell carcinoma by open or robot-assisted partial nephrectomy. Urol Oncol. 2013;31(6):924–9.PubMed Masson-Lecomte A, et al. A prospective comparison of the pathologic and surgical outcomes obtained after elective treatment of renal cell carcinoma by open or robot-assisted partial nephrectomy. Urol Oncol. 2013;31(6):924–9.PubMed
25.
Zurück zum Zitat Peyronnet B, et al. Comparison of 1800 robotic and open partial nephrectomies for renal tumors. Ann Surg Oncol. 2016;23(13):4277–83.PubMed Peyronnet B, et al. Comparison of 1800 robotic and open partial nephrectomies for renal tumors. Ann Surg Oncol. 2016;23(13):4277–83.PubMed
26.
Zurück zum Zitat Choi JE, et al. Comparison of perioperative outcomes between robotic and laparoscopic partial nephrectomy: a systematic review and meta-analysis. Eur Urol. 2015;67(5):891–901.PubMed Choi JE, et al. Comparison of perioperative outcomes between robotic and laparoscopic partial nephrectomy: a systematic review and meta-analysis. Eur Urol. 2015;67(5):891–901.PubMed
27.
Zurück zum Zitat Noone AM, et al. Cancer incidence and survival trends by subtype using data from the surveillance epidemiology and end results program, 1992–2013. Cancer Epidemiol Biomarkers Prev. 2017;26(4):632–41.PubMed Noone AM, et al. Cancer incidence and survival trends by subtype using data from the surveillance epidemiology and end results program, 1992–2013. Cancer Epidemiol Biomarkers Prev. 2017;26(4):632–41.PubMed
28.
Zurück zum Zitat Levy DA, et al. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol. 1998;159(4):1163–7.PubMed Levy DA, et al. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol. 1998;159(4):1163–7.PubMed
29.
Zurück zum Zitat Lam JS, et al. Surveillance following radical or partial nephrectomy for renal cell carcinoma. Curr Urol Rep. 2005;6(1):7–18.PubMed Lam JS, et al. Surveillance following radical or partial nephrectomy for renal cell carcinoma. Curr Urol Rep. 2005;6(1):7–18.PubMed
30.
Zurück zum Zitat Bissada NK, et al. Long-term experience with management of renal cell carcinoma involving the inferior vena cava. Urology. 2003;61(1):89–92.PubMed Bissada NK, et al. Long-term experience with management of renal cell carcinoma involving the inferior vena cava. Urology. 2003;61(1):89–92.PubMed
31.
Zurück zum Zitat Moinzadeh A, Libertino JA. Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same? J Urol. 2004;171(2):598–601.PubMed Moinzadeh A, Libertino JA. Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same? J Urol. 2004;171(2):598–601.PubMed
32.
Zurück zum Zitat Lardas M, et al. Systematic review of surgical management of nonmetastatic renal cell carcinoma with vena caval thrombus. Eur Urol. 2016;70(2):265–80.PubMed Lardas M, et al. Systematic review of surgical management of nonmetastatic renal cell carcinoma with vena caval thrombus. Eur Urol. 2016;70(2):265–80.PubMed
33.
Zurück zum Zitat Wotkowicz C, et al. Management of renal cell carcinoma with vena cava and atrial thrombus: minimal access vs median sternotomy with circulatory arrest. BJU Int. 2006;98(2):289–97.PubMed Wotkowicz C, et al. Management of renal cell carcinoma with vena cava and atrial thrombus: minimal access vs median sternotomy with circulatory arrest. BJU Int. 2006;98(2):289–97.PubMed
34.
Zurück zum Zitat Maxwell NJ, et al. Renal artery embolisation in the palliative treatment of renal carcinoma. Br J Radiol. 2007;80(950):96–102.PubMed Maxwell NJ, et al. Renal artery embolisation in the palliative treatment of renal carcinoma. Br J Radiol. 2007;80(950):96–102.PubMed
35.
Zurück zum Zitat Blom JH, et al. Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol. 2009;55(1):28–34.PubMed Blom JH, et al. Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol. 2009;55(1):28–34.PubMed
36.
Zurück zum Zitat Gershman B, et al. Radical nephrectomy with or without lymph node dissection for high risk nonmetastatic renal cell carcinoma: a multi-institutional analysis. J Urol. 2018;199(5):1143–8.PubMed Gershman B, et al. Radical nephrectomy with or without lymph node dissection for high risk nonmetastatic renal cell carcinoma: a multi-institutional analysis. J Urol. 2018;199(5):1143–8.PubMed
37.
Zurück zum Zitat Zareba P, Pinthus JH, Russo P. The contemporary role of lymph node dissection in the management of renal cell carcinoma. Ther Adv Urol. 2018;10(11):335–42.PubMedPubMedCentral Zareba P, Pinthus JH, Russo P. The contemporary role of lymph node dissection in the management of renal cell carcinoma. Ther Adv Urol. 2018;10(11):335–42.PubMedPubMedCentral
38.
Zurück zum Zitat Flanigan RC, et al. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J Urol. 2004;171(3):1071–6.PubMed Flanigan RC, et al. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J Urol. 2004;171(3):1071–6.PubMed
39.
Zurück zum Zitat Mejean A, et al. Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma. N Engl J Med. 2018;379(5):417–27.PubMed Mejean A, et al. Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma. N Engl J Med. 2018;379(5):417–27.PubMed
41.
Zurück zum Zitat Dabestani S, et al. Local treatments for metastases of renal cell carcinoma: a systematic review. Lancet Oncol. 2014;15(12):e549–e61.PubMed Dabestani S, et al. Local treatments for metastases of renal cell carcinoma: a systematic review. Lancet Oncol. 2014;15(12):e549–e61.PubMed
42.
Zurück zum Zitat Ouzaid I, et al. Surgical metastasectomy in renal cell carcinoma: a systematic review. Eur Urol Oncol. 2019;2(2):141–9.PubMed Ouzaid I, et al. Surgical metastasectomy in renal cell carcinoma: a systematic review. Eur Urol Oncol. 2019;2(2):141–9.PubMed
Metadaten
Titel
Surgery in renal cell carcinoma—when, whom and how?
verfasst von
Sebastian Lenart, MD
Ingrid Berger
Nikolaus Hartig
Stephan Madersbacher
Anton Ponholzer
Publikationsdatum
21.11.2019
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 4/2019
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-019-00548-1

Weitere Artikel der Ausgabe 4/2019

memo - Magazine of European Medical Oncology 4/2019 Zur Ausgabe